Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Doximity, Inc. stock logo
DOCS
Doximity
$57.39
-1.1%
$65.57
$22.96
$85.21
$10.71B1.341.94 million shs687,087 shs
Medtronic plc stock logo
MDT
Medtronic
$88.48
-1.5%
$91.02
$75.96
$96.25
$113.59B0.86.55 million shs2.53 million shs
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Doximity, Inc. stock logo
DOCS
Doximity
-0.50%-12.48%-17.51%+8.83%+115.92%
Medtronic plc stock logo
MDT
Medtronic
+2.63%-0.27%-2.26%+12.57%+3.18%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Doximity, Inc. stock logo
DOCS
Doximity
3.3025 of 5 stars
3.30.00.00.02.94.21.3
Medtronic plc stock logo
MDT
Medtronic
4.3529 of 5 stars
2.24.03.34.02.92.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Doximity, Inc. stock logo
DOCS
Doximity
2.57
Moderate Buy$64.2211.91% Upside
Medtronic plc stock logo
MDT
Medtronic
2.44
Hold$96.078.58% Upside

Current Analyst Ratings Breakdown

Latest MDT and DOCS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/4/2025
Medtronic plc stock logo
MDT
Medtronic
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$92.00 ➝ $107.00
2/19/2025
Medtronic plc stock logo
MDT
Medtronic
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$105.00 ➝ $105.00
2/19/2025
Medtronic plc stock logo
MDT
Medtronic
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$85.00 ➝ $95.00
2/19/2025
Medtronic plc stock logo
MDT
Medtronic
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
2/19/2025
Medtronic plc stock logo
MDT
Medtronic
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$90.00 ➝ $91.00
2/12/2025
Medtronic plc stock logo
MDT
Medtronic
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
2/10/2025
Doximity, Inc. stock logo
DOCS
Doximity
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$55.00 ➝ $65.00
2/10/2025
Doximity, Inc. stock logo
DOCS
Doximity
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$58.00 ➝ $80.00
2/7/2025
Doximity, Inc. stock logo
DOCS
Doximity
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight
2/7/2025
Doximity, Inc. stock logo
DOCS
Doximity
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
2/7/2025
Doximity, Inc. stock logo
DOCS
Doximity
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$60.00 ➝ $71.00
(Data available from 4/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Doximity, Inc. stock logo
DOCS
Doximity
$550.17M19.47$0.71 per share81.32$5.52 per share10.40
Medtronic plc stock logo
MDT
Medtronic
$33.20B3.42$7.25 per share12.21$38.69 per share2.29
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Doximity, Inc. stock logo
DOCS
Doximity
$147.58M$1.0057.3953.634.1036.60%21.75%18.64%N/A
Medtronic plc stock logo
MDT
Medtronic
$3.68B$3.2926.9215.182.2212.83%14.07%7.70%5/21/2025 (Estimated)

Latest MDT and DOCS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/18/2025Q3 2025
Medtronic plc stock logo
MDT
Medtronic
$1.36$1.39+$0.03$1.01$8.33 billion$8.29 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Doximity, Inc. stock logo
DOCS
Doximity
N/AN/AN/AN/AN/A
Medtronic plc stock logo
MDT
Medtronic
$2.803.16%+4.14%85.11%48 Years

Latest MDT and DOCS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/6/2025
Medtronic plc stock logo
MDT
Medtronic
quarterly$0.703%3/28/20253/28/20254/11/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Doximity, Inc. stock logo
DOCS
Doximity
N/A
8.74
8.74
Medtronic plc stock logo
MDT
Medtronic
0.48
1.90
1.39

Institutional Ownership

CompanyInstitutional Ownership
Doximity, Inc. stock logo
DOCS
Doximity
87.19%
Medtronic plc stock logo
MDT
Medtronic
82.06%

Insider Ownership

CompanyInsider Ownership
Doximity, Inc. stock logo
DOCS
Doximity
37.40%
Medtronic plc stock logo
MDT
Medtronic
0.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Doximity, Inc. stock logo
DOCS
Doximity
890186.69 million116.87 millionNot Optionable
Medtronic plc stock logo
MDT
Medtronic
95,0001.28 billion1.28 billionOptionable

Recent News About These Companies

2 Value Stocks I'm Buying Right Now
Top Stock Reports for Mastercard, Medtronic & HCA Healthcare
Stifel Nicolaus Sticks to Its Hold Rating for Medtronic (MDT)
TD Cowen Remains a Buy on Medtronic (MDT)
Why Medtronic Stock Marched Higher on Monday
Medtronic plc stock logo
Medtronic (NYSE:MDT) Trading 1.9% Higher - Here's Why

New MarketBeat Followers Over Time

Media Sentiment Over Time

Doximity stock logo

Doximity NASDAQ:DOCS

$57.35 -0.68 (-1.16%)
As of 01:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Medtronic stock logo

Medtronic NYSE:MDT

$88.49 -1.37 (-1.52%)
As of 01:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.